Advertisement

Topics

Rexahn Pharmaceuticals, Inc. Reports Second Quarter 2017 Financial And Operational Results

20:00 EDT 6 Aug 2017 | BioSpace

ROCKVILLE, Md., Aug. 07, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, today announced financial results for the second quarter ended June 30, 2017 and provided an update on the Company's clinical development programs.We mad...

Original Article: Rexahn Pharmaceuticals, Inc. Reports Second Quarter 2017 Financial And Operational Results

NEXT ARTICLE

More From BioPortfolio on "Rexahn Pharmaceuticals, Inc. Reports Second Quarter 2017 Financial And Operational Results"

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...